Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/19223151
Conclusion of this study
Consistent with prediction the group that took yohimbine hydrochloride prior to exposure sessions showed significantly greater improvement in peak fear at the one-week follow-up behavioral assessment (d=1.68). This was also true across other outcome measures with large to very large effect sizes. These data provide initial support for exposure enhancing effect of single-dose yohimbine hydrochloride in a clinical application.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study